<DOC>
	<DOC>NCT00464438</DOC>
	<brief_summary>This is a 7 day study to evaluate the safety and efficacy of topical gatifloxacin ophthalmic solution for the treatment of bacterial conjunctivitis in subjects from birth to 31 days of age</brief_summary>
	<brief_title>A Study to Evaluate the Safety and Efficacy of Gatifloxacin for the Treatment of Bacterial Conjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis, Bacterial</mesh_term>
	<mesh_term>Gatifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<criteria>diagnosed with bacterial conjunctivitis chemical or foreign body trauma to either eye infection in either eye (besides bacterial conjunctivitis) white spots in the cornea or ulcers in either eye clinical diagnosis of chlamydia or gonorrhea in either eye</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>31 Days</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>